C WorldWide Group’s Vaxcyte PCVX Stock Holding History

C WorldWide Group’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.3M	Hold	195,000	–	–	0.24%	48
2025 Q4	$9M	Hold	195,000	–	–	0.16%	63
2025 Q3	$7.02M	Hold	195,000	–	–	0.11%	67
2025 Q2	$6.34M	Buy	195,000 +100,000	+105%	+$3.28M	0.09%	68
2025 Q1	$3.59M	Buy	+95,000	New	+$7.6M	0.04%	72

Other funds holding PCVX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

C WorldWide Group's PCVX Position: Q1 2026 in Review

C WorldWide Group held its Vaxcyte (PCVX) position steady in Q1 2026 at 195,000 shares worth $11.3M. The position accounts for 0.24% of the portfolio, ranked #48.

C WorldWide Group first reported a position in PCVX in Q1 2025 and has held it in 5 quarters since. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

C WorldWide Group held 195,000 shares of Vaxcyte worth $11.3M as of Q1 2026.
C WorldWide Group left its Vaxcyte share count unchanged in Q1 2026.
Vaxcyte made up 0.24% of C WorldWide Group's portfolio in Q1 2026, its #48 holding.
C WorldWide Group first reported a position in Vaxcyte in Q1 2025 and has held it in 5 quarters since.
336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on C WorldWide Group's 13F filing for Q1 2026, filed 6 May 2026.